[ Mol Therapeutics ]
Complex diseases demand coordinated molecules
Reprogramming the tumor microenvironment. Empowering the immune system where it matters most.
We are developing a next-generation intratumoral immunotherapy platform designed to deliver biologics directly into solid tumors. Our minimally invasive, sustained-release approach aims to enhance immune infiltration, overcome tumor-mediated suppression, and generate durable anti-tumor responses — with an initial focus on high-risk pediatric cancers.
Value Pillars
Localized immunotherapy
Sustained biologic delivery
Engineered tumor remodeling
Reduced systemic toxicity
Mission
Our mission is to transform outcomes for patients with hard-to-treat solid tumors by combining engineering, immunology, and translational oncology into a new class of precision immunotherapy.